Satiety Response of Short Chain Fructooligosaccharide

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

EARLY_PHASE1

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-03-31

Study Completion Date

2009-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Populations that report high fiber consumption demonstrate lower rates of obesity. Enhanced satiety may play a key role in this relationship. The colonic fermentation of fibers is theorized to influence satiety and food intake. Short chain fructooligosaccharide (scFOS) are rapidly fermentable fibers that can easily be added to foods to impact these parameters.

The objective of this study was to evaluate the satiety response of scFOS and its ability to decrease food intake.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Satiety Response of Four Dietary Fibers

NCT01233024

Healthy

COMPLETED EARLY_PHASE1

Resistant Starch and Satiety

NCT01187875

Healthy Adults

COMPLETED EARLY_PHASE1

Satiety, Glycemic, and Gastrointestinal Effects of Novel Fibers

NCT00958399

Healthy

COMPLETED NA

Assessing Fermentability of a Dietary Fiber

NCT01497249

Nutritional Intervention

COMPLETED NA

Prebiotic Fiber as a Modifier of Satiety Hormones and Body Weight in Overweight and Obese Adults

NCT00522353

Obesity

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Intervention study with fiber added to beverages and acute effects on satiety measured.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

No treatment

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

Treatment without scFOS fiber

scFOS 5 g

5 g scFOS

Group Type EXPERIMENTAL

Short chain fructo-oligosaccharide (scFOS) 5 g

Intervention Type DIETARY_SUPPLEMENT

Dietary Supplement: scFOS 5 g

Novel fiber administered in two 5 g doses--the first in a beverage and the second in a solid chew.

scFOS 8 g

8 g scFOS

Group Type EXPERIMENTAL

Short chain fructooligosaccharide (scFOS) 8 g

Intervention Type DIETARY_SUPPLEMENT

Novel fiber administered in two 8 g doses--the first in a beverage and the second in a solid chew.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Short chain fructo-oligosaccharide (scFOS) 5 g

Dietary Supplement: scFOS 5 g

Novel fiber administered in two 5 g doses--the first in a beverage and the second in a solid chew.

Intervention Type DIETARY_SUPPLEMENT

Placebo

Treatment without scFOS fiber

Intervention Type OTHER

Short chain fructooligosaccharide (scFOS) 8 g

Novel fiber administered in two 8 g doses--the first in a beverage and the second in a solid chew.

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

fructo-oligosaccharide

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy men and women
* Age 18-64 years
* Non-smoking
* Not taking medication
* Non-dieting (weight stable in prior 3 months)
* BMI 18-27
* English literacy

Exclusion Criteria

* Do not regularly consume breakfast
* Food allergies to ingredients found in study products
* BMI \<18 or \>27
* Diagnosed cardiovascular, renal, or hepatic disease diabetes mellitus
* Cancer in previous 5 years (except basal cell carcinoma of the skin)
* Any gastrointestinal disease or condition
* Recent bacterial infection (\< 3 months)
* Recent or concurrent participation in an intervention research study
* History of drug or alcohol abuse in prior 6 months
* Use of lipid-lowering, anti-hypertensive, or anti-inflammatory steroid medication
* Eating disorder
* Vegetarians
* People who eat more than approximately 15 grams of fiber per day
* Women who are pregnant or lactating
* Women with irregular menstrual cycles

Minimum Eligible Age

18 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes